1-2 of 2
Raquel Bengio, MD
Close
Sort by
Journal Articles

Real World Efficacy Evaluation of Branded and Copy Imatinib in Chronic Myeloid Leukemia: A Retrospective Multicentric Study from Argentina

Ana Ines Varela, MD, Georgina Bendek, MD, Carolina Pavlovsky, Maria Josefina Freitas, MD, Veronica Ventriglia, MD, Alicia Enrico, MD, Maria Elisa Riva, MD, Mariel Ana Perez, MD, Romina Mariano, MD, Luis Beligoy, MD, Maria Pagani, Ricardo Khalil Tannuri, Irene Larripa, MD, Raquel Bengio, MD, Francisca Rojas, Dardo Riveros, MD, Mariana Raquel Debus, MD, Erica Franceschi, MD, Maria Victoria Osycka, Miguel A. Pavlovsky, MD, Beatriz Moiraghi, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 36–37.
https://doi.org/10.1182/blood-2020-137792
Published: 2020
Journal Articles

Acquired Mutations in the BCR-ABL Kinase Domain in Imatinib Resistant Patients. Multicentric Experience in Argentina and Uruguay.

Patricia Gargallo, MS, Beatriz Moiraghi, MD, Eduardo Bullorsky, MD, Rosa Santarelli, MD, Maria Riva, MD, Alicia Magarino, MD, Ricardo Giuliani, MD, Michele Bianchini, MS, Jorge Milone, MS, Ester Rosenfeld, MD, Santiago Pavlovsky, MD, Emilio Lanari, MD, Adriana Arizo, MD, Celina Avila, MD, Castro R. Miguel, MD, Rafael Conti, MD, Fernanda Alu, MS, Paula Barreyro, MD, Rosario Custidiano, MD, Roberto Bitton, MD, Irene Larripa, PhD, Raquel Bengio, MD
Journal: Blood
Blood (2006) 108 (11): 4811.
https://doi.org/10.1182/blood.V108.11.4811.4811
Published: 2006